Hospitals Urge Health Agency to Block Novo Drug Discount Plan

A group representing over a thousand hospitals participating in a federal drug discount program is asking the US government to block a Novo Nordisk A/S policy that will soon require certain health providers to submit claims data for all dispensing of the company’s drugs.

The coalition, 340B Health, urged in a letter sent Monday to the US Health Resources and Services Administration for the agency to use “all available enforcement options” to prevent Novo from implementing a plan that requires all covered entities under the 340B Drug Pricing Program to submit claims-level data for the dispensing of their drugs.

“Novo ...